Bergman Alan B.
20/20 Biolabs, Inc. Common Stock · Chief Financial Officer
Bergman Alan B. is listed in public filings as officer: Chief Financial Officer. This Bergman Alan B. insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include 20/20 Biolabs, Inc. Common Stock (AIDX). Investors use Bergman Alan B.'s insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $188k100k shares | Grant / ExerciseApr 2, 2026 | $188.0K100k shares | $1.88 | -- |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| Historical actions before the latest disclosure date will appear here after more snapshots are available. | |||||